- Home
- Advocacy
- Latest News and Practice Data
- CAP presses HHS for transparent, safe use of AI in health care
With AI rapidly growing in influence over multiple economic sectors, the CAP has made strong recommendations for health regulators to consider when looking to adopt AI in pathology and laboratory medicine.
The backdrop: The Department of Health and Human Services (HHS) issued a request for information on accelerating the adoption and use of AI in clinical care.
The CAP’s comments, submitted on February 23, focused on safe, effective, and innovative ways AI can strengthen laboratory medicine.
What we’re saying: We emphasized AI’s potential to enhance clinical care while preserving high standards in laboratory medicine.
The impact: Our recommendations to HHS focus on:
- Preserving essential, complementary roles for FDA review of AI-enabled medical devices and software, and CLIA oversight of laboratories.
- Applying lessons from the CAP’s laboratory accreditation experience to AI oversight and quality.
- Ensuring pathologists lead in the selection, validation, and use of AI systems in the laboratory.
The bottom line: The CAP will work with HHS to integrate AI into health care responsibly so tools are reliable, safe, and beneficial for patients and health care teams.
Go deeper: Read our full response.